489P MEN1611 in combination with cetuximab: Targeting PIK3CA mutations in RAS-wild-type patient-derived colorectal cancer xenografts

Autor: Capano, S., Merlino, G., Bigioni, M., Tunici, P., Cottino, F., Zanella, E., Vurchio, V., Bertotti, A., Trusolino, L., Laurent, D.O., Pellacani, A., Binaschi, M.
Zdroj: In Annals of Oncology September 2021 32 Supplement 5:S573-S573
Databáze: ScienceDirect